MedTrace Logo

Study of the Effect of Synchronised Anaemia Management in Chronic Kidney Disease

NCT01763242 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2013-01-08

No results posted yet for this study

Summary

Aims:

1. To establish an electronic process for CKD anaemia management using monthly synchronized dosing of erythrocyte stimulating agents (ESA).
2. To compare this electronic process with "present anaemia management" in the traditional outpatient setting.
3. To monitor Hb targets and clinical endpoints of study groups to model a larger multicentre study focusing on these endpoints.

Conditions

  • Kidney Failure, Chronic
  • Anemia

Interventions

OTHER

EMAN

See details on ESA Synchronization and Dosing in Detailed Description Above

Sponsors & Collaborators

  • Western Health, Australia

    lead OTHER_GOV

Principal Investigators

  • Craig L Nelson, MBBSFRACPPhD · Western Health, Australia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01763242 on ClinicalTrials.gov